Adebrelimab (SHR-1316) in Combination With Chemotherapy as Perioperative Treatment in Patients With Resectable Stage II to III NSCLCs: An Open-Label, Multicenter, Phase 1b Trial-Reference-Cited by-同舟云学术

Adebrelimab (SHR-1316) in Combination With Chemotherapy as Perioperative Treatment in Patients With Resectable Stage II to III NSCLCs: An Open-Label, Multicenter, Phase 1b Trial

Published:2023-02 Issue:2 Volume:18 Page:194-203
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Yan Wanpu,Zhong Wen-Zhao,Liu Yan-Hui,Chen Qixun,Xing Wenqun,Zhang Qin,Liu Lunxu,Ge Di,Chen Keneng,Yang Fan,Lin Xiang,Song Li,Shi Wei,Wu Yi-Long

Funder

Jiangsu Hengrui Medicine

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference30 articles.

1. Adjuvant chemotherapy of completely resected early stage non-small cell lung cancer (NSCLC);Liang;Transl Lung Cancer Res,2013

2. Tumor recurrence after complete resection for non-small cell lung cancer;Taylor;Ann Thorac Surg,2012

3. Detection of micrometastatic tumor cells in pN0 lymph nodes of patients with completely resected nonsmall cell lung cancer: impact on recurrence and survival;Gu;Ann Surg,2002

4. Neoadjuvant therapy in non-small cell lung cancer;Zheng;Surg Oncol Clin N Am,2016

5. Preoperative chemotherapy for non-small-cell lung cancer: a systematic review and meta-analysis of individual participant data;Lancet,2014

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunotherapy revolutionizing brain metastatic cancer treatment: personalized strategies for transformative outcomes;Frontiers in Immunology;2024-07-29

2. Values of circulating tumor DNA for non-small cell lung cancer patients receiving neoadjuvant therapy, progress and challenges: a narrative review;Journal of Thoracic Disease;2024-07

3. Neoadjuvant SHR-1701 with or without chemotherapy in unresectable stage III non-small-cell lung cancer: A proof-of-concept, phase 2 trial;Cancer Cell;2024-07

4. Optimizing perioperative treatment for potentially resectable stage III squamous cell lung carcinoma: promising results of a condensed four-cycle regimen with tislelizumaband chemotherapy;BMC Medicine;2024-06-10

5. Population pharmacokinetics of adebrelimab – Support of alternative flat dose regimen in extensive‐stage small‐cell lung cancer;CPT: Pharmacometrics & Systems Pharmacology;2024-05-06